Milk and milk substitute consumption was linked to an increased risk of liver cancer in a Kuwaiti case-control study, with fatty liver disease mediating about 16% of that effect, but the study does not establish a causal relationship.
The finding comes from a study of 53 histopathologically confirmed hepatocellular carcinoma (HCC) cases drawn from the Kuwait Cancer Control Center Registry, matched against 196 controls recruited at a 1:4 ratio from medical and surgical outpatient clinics at six public hospitals, Nature reported. HCC accounts for approximately 75% of primary liver cancers, making any modifiable risk factor a matter of genuine public health weight.
Why does milk — a dietary staple most guidelines treat as protective — appear here as a risk signal? The researchers had previously flagged heavy alcohol consumption, metabolic dysfunction-associated steatotic liver disease (MASLD), and high consumption of milk and milk substitute as significant HCC risk factors in Kuwait.
This new analysis asked a sharper question: how much of the milk–cancer association runs through MASLD, the fat-accompanied liver condition formerly known as NAFLD?
The answer, using causal mediation analysis within the counterfactual framework, was measurable but partial. The total effect on HCC risk was substantial (odds ratio 5.97; 95% CI 1.69–21.12; p = 0.006), the direct effect independent of MASLD remained significant (OR 4.45; 95% CI 1.27–15.53; p = 0.019), and the indirect effect mediated through MASLD was OR 1.34 (95% CI 1.14–1.57; p < 0.001). On the odds ratio scale, 16.4% of the total effect was mediated through MASLD (95% CI 14.1%–35.4%; p = 0.049) — the proportion the authors suggest could potentially be prevented through interventions targeting MASLD.
Kuwaiti Study Links High Milk Intake to Sixfold Liver Cancer Odds
- In this Kuwaiti study, people with high consumption of milk and milk substitute showed roughly six times the odds of liver cancer compared with those who did not — an association, not proof that milk causes cancer.
- About one-sixth of that association appeared to travel through fatty liver disease (MASLD), meaning managing MASLD could blunt part of the risk.
- Most of the association (the direct effect) remained even after accounting for MASLD, and the authors themselves caution that an unmeasured confounder could explain the mediated result.
Reading the Odds Ratios Without Panic
An odds ratio of 5.97 sounds alarming, but context matters. This was a case-control study: 53 cancer cases versus 196 controls, with data gathered through face-to-face interviews using a standardized questionnaire. Case-control designs establish association and temporal plausibility, not causation, and the confidence interval — the range spanning 1.69 to 21.12 — is wide, reflecting a small sample.
Age skews the picture too. A higher proportion of HCC cases were aged ≥ 60 years compared with controls (79.2% vs. 45.9%), a demographic imbalance the analysis must statistically adjust for and readers should keep in mind.
The study’s own sensitivity analysis delivers the most important caution. The researchers report that the relatively small E-value and its lower bound for the natural indirect effect suggest an unmeasured confounder could potentially explain the observed mediation.
In plain terms: some factor not captured — genetics, viral hepatitis status, diabetes duration, overall dietary pattern — might account for the MASLD-mediated pathway. The authors state plainly that prospective studies are warranted to confirm these findings.
The Kuwait Numbers at a Glance
| Measure | Estimate | 95% CI | p-value |
|---|---|---|---|
| Total effect (MTE) | OR 5.97 | 1.69–21.12 | 0.006 |
| Direct effect (NDE) | OR 4.45 | 1.27–15.53 | 0.019 |
| Indirect effect via MASLD (NIE) | OR 1.34 | 1.14–1.57 | < 0.001 |
| Proportion mediated through MASLD | 16.4% | 14.1%–35.4% | 0.049 |
Why the Middle East Needs Its Own Evidence
The researchers note that evidence on HCC risk factors in Middle Eastern countries, including Kuwait, remains limited. Much of the global liver cancer burden data derives from East Asian and Western cohorts, where alcohol and viral hepatitis dominate.
Kuwait’s profile differs: alcohol consumption is low, yet MASLD prevalence in the region is high, driven by obesity and diabetes. That makes dietary signals — like this milk and milk substitute finding — proportionally more visible in Gulf populations than they might be elsewhere.
The mediation result also carries a practical public health lever. Because 16.4% of the association ran through MASLD, the authors suggest that dietary modification, alongside systematic screening and management of MASLD, may help reduce HCC risk. For Gulf health systems, that points toward strengthening metabolic liver disease screening pathways rather than issuing blanket dietary warnings about milk.
On funding: the published study material available for this report does not name its funding sources, so readers should treat the financial disclosure question as open until the full paper’s declarations are examined.
Consult a Doctor If You Have Fatty Liver Risk Factors or Warning Signs
The findings are observational, derived from a small Kuwaiti sample, and the authors themselves flag the possibility of unmeasured confounding. For most people, dairy remains part of a balanced diet under established dietary guidance.
Consult a physician promptly if you have known risk factors for fatty liver disease — obesity, type 2 diabetes, elevated liver enzymes, or metabolic syndrome — and discuss whether MASLD screening is appropriate.
Seek medical evaluation for warning signs that warrant investigation: unexplained weight loss, persistent fatigue, abdominal swelling or pain, or jaundice (yellowing of the skin or eyes). Patients already diagnosed with MASLD should follow their clinician’s management plan rather than altering their diet based on this single study.
Where the Evidence Goes Next
The trajectory here is clear and modest. A case-control signal from 53 cases in Kuwait has identified a hypothesis worth testing: that dairy consumption and MASLD interact in liver carcinogenesis. Prospective cohort studies — following healthy populations forward in time — are the authors’ stated next step. Until those results arrive, the study’s contribution is a directional clue for researchers in understudied regions, not a dietary directive for the public.
References
- Nature portfolio: Milk and milk substitute consumption and hepatocellular carcinoma risk: the mediating role of metabolic dysfunction-associated steatotic liver disease (case-control study, Kuwait Cancer Control Center Registry, 53 HCC cases and 196 controls).
- Kuwait Cancer Control Center Registry — source of histopathologically confirmed HCC cases.
Consult a qualified healthcare professional regarding any personal health decisions.
- Lee Se-young Credits 8-Kilogram Weight Loss to Low-Carb Diet for ‘The Remarried Empress’ Role
- Memphis Doctors Warn Antibiotic Misuse Fuels Resistance Crisis
- ATM rs189037 Linked to 2.19x Lung Cancer Risk in Bangladeshi Men (archyworldys.com)
- Pope Leo XIV Cleared for South America Tour After Lung Cancer Surgery (newsdirectory3.com)